Medistim ASA

OB-MEDI

Basic

Market Cap
NOK 3,223.3M
EV
NOK 3,062.1M
Shares Out
18.31M
Revenue
NOK 525.64M
Employees
151

Margins

Gross
78.81%
EBITDA
27.91%
Operating
24.74%
Pre-Tax
25.05%
Net
19.51%
FCF
22.5%

Returns (5Yr Avg)

ROA
24.08%
ROTA
35.57%
ROE
31.18%
ROCE
37.3%
ROIC
33.37%

Valuation (TTM)

P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—

Valuation (NTM)

Price Target
NOK 190
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—

Financial Health

Cash
NOK 170.26M
Net Debt
-NOK 161.2M
Debt/Equity
0.02
EBIT/Interest
861.31

Growth (CAGR)

Rev 3Yr
13.9%
Rev 5Yr
9.26%
Rev 10Yr
10.5%
Dil EPS 3Yr
13.4%
Dil EPS 5Yr
9.92%
Dil EPS 10Yr
14.58%
Rev Fwd 2Yr
3.44%
EBITDA Fwd 2Yr
7.79%
EPS Fwd 2Yr
6.71%
EPS LT Growth Est
14.6%

Dividends

Yield
—
Payout
80.22%
DPS
NOK 4.5
DPS Growth 3Yr
14.47%
DPS Growth 5Yr
14.87%
DPS Growth 10Yr
18.85%
DPS Growth Fwd 2Yr
-13.38%

Metric	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	LTM
Total Revenues						356.9	356.2	417.8	486.3	521.1	525.6
Total Revenues % Chg.						10.5%	-0.2%	17.3%	16.4%	7.2%	5.3%
Cost of Goods Sold, Total						80.1	76.6	97.1	106.5	112.3	111.4
Gross Profit						276.8	279.6	320.7	379.8	408.8	414.3
Selling General & Admin Expenses, Total						116.1	108.4	124	136.5	150.2	155.8
Depreciation & Amortization						18	23.1	23.4	23.3	23.7	24.2
Other Operating Expenses						52.9	52.6	62.3	78.7	103.5	104.2
Other Operating Expenses, Total						187	184.1	209.7	238.5	277.4	284.2
Operating Income						89.8	95.5	111	141.3	131.4	130.1
Interest Expense, Total						-0.4	-0.1	-0.2	-0.1	-0.2	-0.2
Interest And Investment Income						0.2	0	0	0.9	3.3	3.9
Net Interest Expenses						-0.3	-0.1	-0.2	0.8	3.1	3.7
Currency Exchange Gains (Loss)						1.7	-3.5	-1.8	3.1	0.9	-1.5
Other Non Operating Income (Expenses)			—			-0.2	-0.3	-0.2	0.9	-0.3	-0.6
EBT, Excl. Unusual Items						91	91.6	108.8	146.1	135.2	131.7
Restructuring Charges	—		—	—	—	—	—	—	—	—	—
Other Unusual Items	—	—	—	—	—	—	—	5.3	—	—	—
EBT, Incl. Unusual Items						91	91.6	114.1	146.1	135.2	131.7
Income Tax Expense						20.7	22.2	23.2	32.1	31.4	29.1
Earnings From Continuing Operations						70.3	69.4	90.9	114	103.8	102.5
Net Income						70.3	69.4	90.9	114	103.8	102.5
Net Income to Common Incl Extra Items						70.3	69.4	90.9	114	103.8	102.5
Net Income to Common Excl. Extra Items						70.3	69.4	90.9	114	103.8	102.5
Total Shares Outstanding						18.2	18.2	18.2	18.3	18.3	18.3
Weighted Avg. Shares Outstanding						18.2	18.2	18.2	18.2	18.3	18.3
Weighted Avg. Shares Outstanding Dil						18.2	18.2	18.2	18.3	18.3	18.3
EPS						3.9	3.8	5	6.2	5.7	5.6
EPS Diluted						3.9	3.8	5	6.2	5.7	5.6
EBITDA						102.1	105.1	127.3	157.5	146.7	146.7
Effective Tax Rate						22.8%	24.3%	20.3%	22%	23.2%	22.1%